Άρθρα με εντολές δημόσιας πρόσβασης - Gerald F WattsΜάθετε περισσότερα
ΣύνολοNHMRCNIHGovernment of SpainMedical Research Future Fund, AustraliaCIHRNIHRBHFMRCWellcomeHSFSwedish Research CouncilEuropean CommissionAHANWOFondazione CariploBusiness FinlandVANSERCNSFCMESTDGovernment of ItalyUK Research & InnovationGatesDoDGenome CanadaDFFTekesINSERMHRBKnut and Alice Wallenberg FoundationZonMwANRNMRCJDRFNational Research Foundation, SingaporeLeducq Foundation, USAHealth Data Research, UK
Δεν είναι διαθέσιμο πουθενά: 47
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
EMM Ooi, PHR Barrett, DC Chan, GF Watts
Clinical science 114 (10), 611-624, 2008
Εντολές: US National Institutes of Health
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein (a)
MJ Koren, PM Moriarty, SJ Baum, J Neutel, M Hernandez-Illas, ...
Nature medicine 28 (1), 96-103, 2022
Εντολές: American Heart Association
Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action
KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ...
JAMA cardiology 5 (2), 217-229, 2020
Εντολές: UK Medical Research Council
Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies
DC Chan, J Pang, G Romic, GF Watts
Current atherosclerosis reports 15, 1-9, 2013
Εντολές: National Health and Medical Research Council, Australia
Elevated lipoprotein (a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial …
DC Chan, J Pang, AJ Hooper, JR Burnett, DA Bell, TR Bates, ...
International journal of cardiology 201, 633-638, 2015
Εντολές: National Health and Medical Research Council, Australia
The renaissance of lipoprotein (a): brave new world for preventive cardiology?
KL Ellis, MB Boffa, A Sahebkar, ML Koschinsky, GF Watts
Progress in Lipid Research 68, 57-82, 2017
Εντολές: Canadian Institutes of Health Research, Heart and Stroke Foundation of …
Lipoprotein (a): Knowns, unknowns and uncertainties
M Ruscica, CR Sirtori, A Corsini, GF Watts, A Sahebkar
Pharmacological research 173, 105812, 2021
Εντολές: Fondazione Cariplo
Prevalence of familial hypercholesterolemia in adolescents: potential value of universal screening?
J Pang, AC Martin, TA Mori, LJ Beilin, GF Watts
The Journal of pediatrics 170, 315-316, 2016
Εντολές: National Health and Medical Research Council, Australia
The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies
EMM Ooi, PHR Barrett, GF Watts
International journal of cardiology 168 (3), 1811-1818, 2013
Εντολές: National Health and Medical Research Council, Australia
The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia
DC Chan, PHR Barrett, GF Watts
Best practice & research Clinical endocrinology & metabolism 28 (3), 369-385, 2014
Εντολές: National Health and Medical Research Council, Australia
Improving clinical practice guidelines with implementation science
MN Sarkies, LK Jones, SS Gidding, GF Watts
Nature Reviews Cardiology 19 (1), 3-4, 2022
Εντολές: US National Institutes of Health, National Health and Medical Research …
Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 expert panel statement, main text
GD Kolovou, GF Watts, DP Mikhailidis, P Pérez-Martínez, S Mora, ...
Current Vascular Pharmacology 17 (5), 498-514, 2019
Εντολές: US National Institutes of Health
Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope …
DC Chan, ATY Wong, J Pang, PHR Barrett, GF Watts
Clinical Science 128 (6), 379-385, 2015
Εντολές: National Health and Medical Research Council, Australia
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?
Z Ademi, R Norman, J Pang, D Liew, S Zoungas, E Sijbrands, BA Ference, ...
Atherosclerosis 304, 1-8, 2020
Εντολές: Medical Research Future Fund, Australia
Effect of lipoprotein (a) on the diagnosis of familial hypercholesterolemia: does it make a difference in the clinic?
DC Chan, J Pang, AJ Hooper, DA Bell, JR Burnett, GF Watts
Clinical Chemistry 65 (10), 1258-1266, 2019
Εντολές: Medical Research Future Fund, Australia
Lipoprotein (a) and secondary prevention of atherothrombotic events: a critical appraisal
MB Boffa, S Stranges, N Klar, PM Moriarty, GF Watts, ML Koschinsky
Journal of clinical lipidology 12 (6), 1358-1366, 2018
Εντολές: Canadian Institutes of Health Research, Heart and Stroke Foundation of …
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men
EMM Ooi, GF Watts, DC Chan, LB Nielsen, P Plomgaard, B Dahlbäck, ...
Atherosclerosis 210 (1), 326-330, 2010
Εντολές: Swedish Research Council
Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: a FIELD substudy
JA Harmer, AC Keech, AS Veillard, MR Skilton, TH Marwick, GF Watts, ...
Atherosclerosis 242 (1), 295-302, 2015
Εντολές: National Health and Medical Research Council, Australia
Variation in Niemann–Pick C1‐like 1 gene as a determinant of apolipoprotein B‐100 kinetics and response to statin therapy in centrally obese men
DC Chan, GF Watts, J Wang, RA Hegele, FM Van Bockxmeer, ...
Clinical endocrinology 69 (1), 45-51, 2008
Εντολές: US National Institutes of Health
Lipid management in people with peripheral artery disease
J Golledge, NC Ward, GF Watts
Current Opinion in Lipidology 30 (6), 470-476, 2019
Εντολές: National Health and Medical Research Council, Australia
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή